NEOSTIGMINE METHYLSULFATE
NDC 0548-9601, neostigmine methylsulfate, injection, from Amphastar Pharmaceuticals, Inc..
- Product NDC
- 0548-9601
- Status
- Listed
- Labeler
- Amphastar Pharmaceuticals, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209933
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0548-9601 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEOSTIGMINE METHYLSULFATE.5 mg/mL
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0548-9601-00 | 00548960100 | 10 CARTON in 1 PACKAGE (0548-9601-00) / 1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e47a4a4c-0e7c-40b6-9950-5b3adadcac22
Use it
Look up 0548-9601 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0548-9601 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0548-9601. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.